Is resveratrol really effective in kidney disease?: A different perspective than ever before.
| Autor: | Kemaneci S; Department of Nutrition and Dietetics, Faculty of Health Sciences, Burdur Mehmet Akif Ersoy University, Burdur, Turkey., Keser A; Department of Nutrition and Dietetics, Faculty of Health Sciences, Ankara University, Ankara, Turkey., Özmen Ö; Department of Veterinary Pathology, Faculty of Veterinary, Burdur Mehmet Akif Ersoy University, Burdur, Turkey. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Immunopharmacology and immunotoxicology [Immunopharmacol Immunotoxicol] 2024 Aug; Vol. 46 (4), pp. 461-469. Date of Electronic Publication: 2024 May 29. |
| DOI: | 10.1080/08923973.2024.2360067 |
| Abstrakt: | Background: Chronic kidney disease (CKD) is a global health problem and it is stated that the use of resveratrol supplement contributes to the protection of kidney health. In this study, it was aimed to evaluate the effect of resveratrol supplementation on kidney function, inflammation and histopathological findings in rats with experimental adenine-induced kidney damage. Methods: Three different groups of 10 randomly selected rats were formed. The first group was the negative control group, the second group was the uremic control group (KDG), and the third group was the group in which uremia was created and resveratrol was applied (RG). Kidney damage was induced by administration of 200 mg/kg adenine. Resveratrol supplementation was administered at 20 mg/kg after kidney damage. Serum urea, creatinine, indoxyl sulfate (IS), p-cresol, glomerular filtration rate, C-reactive protein (CRP); interleukin (IL)-6 and tumor necrosis factor (TNF)-α gene expression levels and histopathological findings were evaluated. Results: It was determined that resveratrol supplement applied after the formation of connective tissue in renal failure didn't have an improvement effect on the urine amount, kidney function and inflammatory parameters and histopathological changes ( p > 0.05). Just, the increase in the CRP value of KDG ( p < 0.05) was not observed in RG. Conclusion: The findings suggest that resveratrol administered after kidney damage with adenine has no effect on kidney disease. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|